Cargando…

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is one of the most important chronic liver diseases worldwide and has garnered increasing attention in recent decades. NAFLD is characterized by a wide range of liver changes, from simple steatosis to nonalcoholic steatohepatitis, cirrhosis, and hepatocellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Guanliang, Ni, Yinhua, Nagata, Naoto, Xu, Liang, Ota, Tsuguhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037659/ https://www.ncbi.nlm.nih.gov/pubmed/27563875 http://dx.doi.org/10.3390/ijms17091379

Ejemplares similares

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
por: Kitade, Hironori, et al.
Publicado: (2017)

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
por: Xu, Liang, et al.
Publicado: (2019)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
por: Pickett-Blakely, Octavia, et al.
Publicado: (2018)

Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
por: Xu, Liang, et al.
Publicado: (2017)

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
por: Xu, Liang, et al.
Publicado: (2019)

Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice
por: Xu, Liang, et al.
Publicado: (2018)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases
por: Ezhilarasan, Devaraj, et al.
Publicado: (2022)

Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease
por: Kato, Ken-ichiro, et al.
Publicado: (2014)

Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
por: Fuke, Nobuo, et al.
Publicado: (2019)

Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
por: Nishikawa, Tomoki, et al.
Publicado: (2020)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice
por: Kobori, Masuko, et al.
Publicado: (2014)

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E
por: Ni, Yinhua, et al.
Publicado: (2015)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Clinico‐histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease
por: Fujiwara, Naoto, et al.
Publicado: (2023)

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
por: Kita, Yuki, et al.
Publicado: (2012)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

An Update on the Chemokine System in the Development of NAFLD
por: Nagata, Naoto, et al.
Publicado: (2022)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Genetic predisposition in nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

DNA Methylation in Nonalcoholic Fatty Liver Disease
por: Hyun, Jeongeun, et al.
Publicado: (2020)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
por: Li, Andrew A., et al.
Publicado: (2020)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
por: Frasinariu, Otilia, et al.
Publicado: (2022)

Combination Therapies for Nonalcoholic Fatty Liver Disease
por: Makri, Evangelia S., et al.
Publicado: (2022)

Nutritional Genomics in Nonalcoholic Fatty Liver Disease
por: Vasconcellos, Carolina, et al.
Publicado: (2023)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pb5pi2bbqv1qn7j1h7h7dbi3ni